Results 61 to 70 of about 33,530 (249)

Prophylactic Enoxaparin Reduces Symptomatic Venous Thromboembolism Compared With No Chemoprophylaxis Within 95 Days After Knee Arthroscopy

Arthroscopy, EarlyView.
Purpose To investigate whether prophylactic use of low‐molecular‐weight heparin (enoxaparin) after knee arthroscopy reduces the incidence of symptomatic venous thromboembolism (VTE) compared with no postoperative pharmacological prophylaxis. Methods We conducted a population‐based cohort study using linked national insurance and hospital data from ...
Aylin Albrecht, Lorenz Kapral, Felix Gruber, Christoph Dibiasi, Oliver Kimberger, Christian Albrecht   +5 more
wiley   +1 more source

EmPHasis‐10 Health‐Related Quality of Life and Exercise Capacity in Chronic Thromboembolic Pulmonary Hypertension After Balloon Angioplasty

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Whether pulmonary hemodynamic parameters and functional capacity are associated with quality of life in patients with chronic thromboembolic pulmonary hypertension remains unknown.
Hayato Sakamoto, Ayumi Goda, Kazuki Tobita, Kaori Takeuchi, Hanako Kikuchi, Takumi Inami, Yuichi Tamura, Takashi Kohno, Shin Yamada, Kyoko Soejima, Toru Satoh   +10 more
doaj   +1 more source

Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study

British Journal of Clinical Pharmacology, EarlyView.
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind, Niclas Eriksson, Marco Cavalli, Yiyi Xu, Fredrik Nyberg, Anders Sundström, Mia Wadelius, Pär Hallberg   +7 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study

Pulmonary Circulation, 2020
Pulmonary endarterectomy is the guideline recommended treatment for chronic thromboembolic pulmonary hypertension, in addition to life-long anticoagulation therapy.
Janica Kallonen, Natalie Glaser, Fredrik Bredin, Matthias Corbascio, Ulrik Sartipy   +4 more
doaj   +1 more source

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients

, 2018
Abbreviated versions of the risk stratification strategy of the European Society of Cardiology (ESC)/European Respiratory Society (ERS) pulmonary hypertension guidelines have been recently validated in patients with pulmonary arterial hypertension.
Grünig, Ekkehard, Olsson, Karen M., Gruenig, Ekkehard, Staehler, Gerd, Opitz, Christian F., Vonk-Noordegraaf, Anton, Pepke-Zaba, Joanna, Halank, Michael, Klose, Hans, Pittrow, David, Hoeper, Marius M., Gibbs, J. Simon R., Delcroix, Marion, Held, Matthias, Gall, Henning, Rosenkranz, Stephan, Tsangaris, Iraklis, Huscher, Doerte, Lange, Tobias J.   +18 more
core   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

A Case of Chronic Thromboembolic Pulmonary Hypertension and Pregnancy, Managed With Pulmonary Endarterectomy: Clinical Challenges, Case Report, and Literature Review [PDF]

Clin Case Rep
ABSTRACT Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, potentially curable form of pulmonary hypertension, with limited data in pregnancy. We describe a 37‐year‐old woman with progressive dyspnea, back pain, and cough, whose evaluation revealed severe right ventricular enlargement, high pulmonary pressures, and extensive V/Q ...
Ahangar H, Ghasemi Palangi M, Gohari S, Yasami P.   +3 more
europepmc   +2 more sources

Vascular and right ventricular remodeling in chronic thromboembolic pulmonary hypertension.

, 2012
In chronic thromboembolic pulmonary hypertension (CTEPH) increased pulmonary vascular resistance is caused by fibrotic organization of unresolved thromboemboli.
Delcroix, Marion, Vonk-Noordegraaf, A., Lang, Irene M., Simonneau, G., Simonneau, Gerald, Vonk-Noordegraaf, Anton, Delcroix, M., Fadel, E., Naeije, R., Lang, I., Fadel, Elie, Naeije, Robert   +11 more
core   +1 more source

Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension

, 2021
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) are both associated with right ventricular (RV) failure and mortality.
de Man, Frances S., Bogaard, Harm Jan, Marcus, J. Tim, Vonk Noordegraaf, Anton, Nossent, Esther J., van Leeuwen, Joost W., Ruigrok, Dieuwertje, Meijboom, Lilian J., Braams, Natalia J.   +8 more
core   +1 more source